pharma · Osteopenia · Heat Stress · PTPI
Petros Pharmaceuticals
Petros Pharmaceuticals is a pharma organization headquartered in New York, USA. It trades on NYSE under ticker PTPI. Primary therapeutic focus areas include Osteopenia, Heat Stress, Risk of Heat Stress. NovaPharmaNews li
New York, USA HQ
3 Employees
Public company Type
PTPI · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Employees
- 3
- Programs
- 3
- Drugs
- 3
- Patents
- 0
Colostrum supplementation for bone loss
Unknown · other · Osteopenia
Colostrum supplementation for bone loss for Osteopenia is a Unknown program (other) at Petros Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code 3. Colostrum & bone
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Petros Pharmaceuticals
- Phase
- Unknown
- Modality
- other
- Indication
- Osteopenia
- Status
- completed
- Trials
- 1